Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study.

Blom DJ, O'Dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muñiz-Grijalvo O, Santos RD, Baum S, Witztum JL.

J Clin Lipidol. 2018 Sep - Oct;12(5):1234-1243.e5. doi: 10.1016/j.jacl.2018.05.013. Epub 2018 May 31.

PMID:
30318066
2.

Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation.

Kose E, Armagan C, Teke Kısa P, Onay H, Arslan N.

J Pediatr Endocrinol Metab. 2018 Oct 11. pii: /j/jpem.ahead-of-print/jpem-2018-0280/jpem-2018-0280.xml. doi: 10.1515/jpem-2018-0280. [Epub ahead of print]

PMID:
30307897
3.

Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.

Falko JM.

Endocr Pract. 2018 Aug;24(8):756-763. doi: 10.4158/EP-2018-0157.

PMID:
30183397
4.

Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes.

Shah NP, Cho L, Ahmed HM.

J Am Coll Cardiol. 2018 Sep 4;72(10):1177-1179. doi: 10.1016/j.jacc.2018.06.042. No abstract available.

PMID:
30165992
5.

Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.

Ariza MJ, Rioja J, Ibarretxe D, Camacho A, Díaz-Díaz JL, Mangas A, Carbayo-Herencia JA, Ruiz-Ocaña P, Lamíquiz-Moneo I, Mosquera D, Sáenz P, Masana L, Muñiz-Grijalvo O, Pérez-Calahorra S, Valdivielso P; Spanish Dyslipidemia Registry.

J Clin Lipidol. 2018 Aug 1. pii: S1933-2874(18)30353-2. doi: 10.1016/j.jacl.2018.07.013. [Epub ahead of print]

PMID:
30150141
6.

New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.

Serveaux Dancer M, Di Filippo M, Marmontel O, Valéro R, Piombo Rivarola MDC, Peretti N, Caussy C, Krempf M, Vergès B, Mahl M, Marçais C, Moulin P, Charrière S.

J Clin Lipidol. 2018 Sep - Oct;12(5):1244-1252. doi: 10.1016/j.jacl.2018.06.018. Epub 2018 Jul 7.

PMID:
30037590
7.

Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.

Marco-Benedí V, Lamiquiz-Moneo I, Álvarez-Sala LA, Civeira F.

Atherosclerosis. 2018 Aug;275:342-345. doi: 10.1016/j.atherosclerosis.2018.06.870. Epub 2018 Jun 21.

PMID:
30015297
8.

Identifying suspected familial chylomicronemia syndrome.

Rengarajan R, McCullough PA, Chowdhury A, Tecson KM.

Proc (Bayl Univ Med Cent). 2018 May 21;31(3):284-288. doi: 10.1080/08998280.2018.1463784. eCollection 2018 Jul.

9.

A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.

Kristensen KK, Midtgaard SR, Mysling S, Kovrov O, Hansen LB, Skar-Gislinge N, Beigneux AP, Kragelund BB, Olivecrona G, Young SG, Jørgensen TJD, Fong LG, Ploug M.

Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6020-E6029. doi: 10.1073/pnas.1806774115. Epub 2018 Jun 13.

PMID:
29899144
10.

The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study.

Arca M, Hsieh A, Soran H, Rosenblit P, O'Dea L, Stevenson M.

Expert Rev Cardiovasc Ther. 2018 Jul;16(7):537-546. doi: 10.1080/14779072.2018.1487290. Epub 2018 Jun 22.

PMID:
29889589
11.

Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.

Chaudhry R, Viljoen A, Wierzbicki AS.

Expert Rev Clin Pharmacol. 2018 Jun;11(6):589-598. doi: 10.1080/17512433.2018.1480368. Epub 2018 Jun 11. Review.

PMID:
29842811
12.

Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.

Williams L, Rhodes KS, Karmally W, Welstead LA, Alexander L, Sutton L; patients and families living with FCS.

J Clin Lipidol. 2018 Jul - Aug;12(4):908-919. doi: 10.1016/j.jacl.2018.04.010. Epub 2018 Apr 27.

13.

The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.

Davidson M, Stevenson M, Hsieh A, Ahmad Z, Roeters van Lennep J, Crowson C, Witztum JL.

J Clin Lipidol. 2018 Jul - Aug;12(4):898-907.e2. doi: 10.1016/j.jacl.2018.04.009. Epub 2018 Apr 26.

14.

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.

Hegele RA, Berberich AJ, Ban MR, Wang J, Digenio A, Alexander VJ, D'Erasmo L, Arca M, Jones A, Bruckert E, Stroes ES, Bergeron J, Civeira F, Witztum JL, Gaudet D.

J Clin Lipidol. 2018 Jul - Aug;12(4):920-927.e4. doi: 10.1016/j.jacl.2018.03.093. Epub 2018 Apr 4.

15.

Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management.

Brown WV, Goldberg I, Duell B, Gaudet D.

J Clin Lipidol. 2018 Mar - Apr;12(2):254-263. doi: 10.1016/j.jacl.2018.02.018. Epub 2018 Mar 5. Review.

PMID:
29534878
16.

The prevalence and etiology of extreme hypertriglyceridemia in children: Data from a tertiary children's hospital.

Patni N, Li X, Adams-Huet B, Garg A.

J Clin Lipidol. 2018 Mar - Apr;12(2):305-310. doi: 10.1016/j.jacl.2018.01.003. Epub 2018 Jan 12.

PMID:
29454679
17.

Roundtable on etiology of familial chylomicronemia syndrome.

Brown WV, Gaudet D, Goldberg I, Hegele R.

J Clin Lipidol. 2018 Jan - Feb;12(1):5-11. doi: 10.1016/j.jacl.2017.12.015. Epub 2017 Dec 29. Review. No abstract available.

PMID:
29452917
18.

A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.

Paquette M, Hegele RA, Paré G, Baass A.

J Clin Lipidol. 2018 Mar - Apr;12(2):506-510. doi: 10.1016/j.jacl.2018.01.011. Epub 2018 Jan 31.

PMID:
29452893
19.

Hospital Management of Severe Hypertriglyceridemia in Children.

Valaiyapathi B, Ashraf AP.

Curr Pediatr Rev. 2017;13(4):225-231. doi: 10.2174/1573400514666180117092707. Review.

PMID:
29345595
20.

Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.

Caddeo A, Mancina RM, Pirazzi C, Russo C, Sasidharan K, Sandstedt J, Maurotti S, Montalcini T, Pujia A, Leren TP, Romeo S, Pingitore P.

Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):158-164. doi: 10.1016/j.numecd.2017.11.003. Epub 2017 Nov 22.

Supplemental Content

Loading ...
Support Center